Peracchia A, Sarli L, Pietra N, Choua O, Maggiore S M
Istituto di Clinica Chirurgica Generale e Terapia Chirurgica, Università degli Studi di Parma.
Ann Ital Chir. 1995 Jan-Feb;66(1):69-83.
By the term of local recurrence (LR), after apparently curative resection of a colorectal cancer, we mean the recurrence of the disease at the site of the original tumor, in correspondence to the regional lymph nodes or to intestinal anastomosis. The frequency of LR, which differs widely from one case to another because of the unhomogenity of the samples under examination, is on average around 16%, although this figure is to be considered an underestimation since it is not supported by routine autopsies. The authors analyse, together with the data in the literature, the results of their personal experience relating to 1164 patients undergoing surgery for colorectal cancer in the space of 18 years, in order to evaluate the true effectiveness of surgery on patients affected by LR. Surgery on the original tumor had a curative aim in 791 (68%) of these cases, 33 patients died during the postoperative period and 37 were lost to follow-up. Among the remaining 721 patients, recurrence was observed in 218 cases (30.2%): in 81 of these was confirmed a LR, with simultaneous distant metastasis in 45. During the same time span, 15 patients were admitted who were affected by LR from colorectal cancers treated surgically in other hospitals. Of these, only 2 had concomitant distant metastasis. 58 of these 96 patients (60.4%) underwent surgery, which had a curative aim in 22 cases (37.9%)/ Up to present, 12 patients undergoing curative surgery are still alive, 4 (33.3%) being affected by further relapse. The data reported demonstrate that in patients with proven LR surgical intervention is widely indicated, being the only therapeutic approach able to provide tangible results. However, the choice of exeresis must be carefully weighed: surgery of LR can be said to be truly curative in few cases, and thus the operative risks may not be acceptable in situations where limited results, in terms of duration and quality, are foreseen.
关于局部复发(LR),我们指的是在结直肠癌看似根治性切除术后,疾病在原发肿瘤部位、对应区域淋巴结或肠吻合口处复发。由于所检查样本的不均一性,LR的发生率在不同病例间差异很大,平均约为16%,不过由于缺乏常规尸检数据支持,这个数字应被视为低估。作者结合文献数据,分析了他们在18年期间对1164例接受结直肠癌手术患者的个人经验结果,以评估手术对LR患者的真正疗效。其中791例(68%)对原发肿瘤进行的手术具有治愈目的,33例患者在术后期间死亡,37例失访。在其余721例患者中,观察到218例复发(30.2%):其中81例确诊为LR,45例同时伴有远处转移。在同一时间段内,收治了15例在其他医院接受过手术治疗的结直肠癌LR患者。其中只有2例伴有远处转移。这96例患者中有58例(60.4%)接受了手术,其中22例(37.9%)的手术具有治愈目的。截至目前,12例接受根治性手术的患者仍然存活,4例(33.3%)出现了进一步复发。所报告的数据表明,对于已证实为LR的患者,手术干预被广泛推荐,是唯一能够产生切实效果的治疗方法。然而,切除方式的选择必须仔细权衡:LR手术在少数情况下可被视为真正治愈性的,因此在预见疗效有限(无论是持续时间还是质量方面)的情况下,手术风险可能是不可接受的。